"Your donation allows us to keep sending journalists to speak to both sides of the story. The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it."
"A man who was left struggling to speak and eat properly due to tongue cancer has renewed hope after starting a trial for a new smart jab. Carl Walsh, 59, from Birmingham, was diagnosed with tongue cancer in May 2024 after his swollen mouth left him in agony. Before starting the trial, I couldn't talk properly and eating was difficult, but the swelling has gone down a lot, and I'm not in the same amount of pain I used to be in, Mr Walsh said. Sometimes I even forget that I have cancer."
The Independent emphasizes on-the-ground reporting across issues like reproductive rights, climate change and Big Tech and relies on donations to fund journalists while keeping content free of paywalls. A Birmingham man, Carl Walsh, was diagnosed with tongue cancer in May 2024 after severe swelling and initial treatment proved unsuccessful. He began a trial at the Royal Marsden NHS Foundation Trust in July for a new subcutaneous cancer jab, amivantamab. The triple-action therapy has been shown to shrink head and neck cancers in more than three in four patients and also helps activate the immune system. Walsh reports reduced swelling, less pain, and improved speech and eating.
Read at www.independent.co.uk
Unable to calculate read time
Collection
[
|
...
]